Comparison of the effects of monotherapy with exenatide or metformin to combined exenatide and metformin therapy on menstrual cyclicity in overweight women with polycystic ovary syndrome

Trial Profile

Comparison of the effects of monotherapy with exenatide or metformin to combined exenatide and metformin therapy on menstrual cyclicity in overweight women with polycystic ovary syndrome

Completed
Phase of Trial: Phase II

Latest Information Update: 18 Aug 2012

At a glance

  • Drugs Exenatide; Metformin
  • Indications Obesity; Polycystic ovary syndrome; Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 07 Sep 2008 Results presented at the 44th Annual Meeting of the European Association for the Study of Diabetes.
    • 11 Jul 2007 Status change from in progress to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top